advisorsecurities master

NXLNexalin Technology, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key
19468
Ticker
NXL
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2022-09-16
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
NXL

Detail

Enriched 2026-08-14 20:47

Market cap
$7,825,017.86
Shares outstanding (class)
22,011,302
Shares outstanding (weighted)
22,011,302
SIC
3845 ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Employees
8
Location
HOUSTON, TX
Description

Nexalin Technology Inc designs and develops neurostimulation products and bioelectronic medical technology to treat anxiety and insomnia without drugs or psychotherapy. The Company has developed the Generation 1 (Gen 1) medical device, a cranial electrotherapy stimulation (CES) device classified by the U.S. Food and Drug Administration (FDA) as a Class II device. The Company operates as a single operating and reportable segment, focused on the design and development of innovative neurostimulation products. The Company focuses on treating mental health conditions without reliance on drugs or psychotherapy. Geographically, it generates sales in the USA and China, with China generating the maximum sales.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data